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Abstract
Background: Neonatal Lupus Erythematosus (NLE) is an uncommon autoimmune disease characterized by
cutaneous, hepatic, hematological, neurological and cardiac involvement.
Case presentation: Here we report four cases of cutaneous NLE which were referred to our department in the last
10 years and update literature. The newborns presented with different skin, clinical and laboratory features. This
underlines the phenotypic variability of NLE. We investigated the passage of maternal antinuclear antibodies (ANA)
and extractable nuclear antigen antibodies (ENA) - particularly anti-Ro/SSA, anti-La/SSB and anti-U1
ribonucleoprotein RNP - through the placenta. Despite the positive family background, cutaneous NLE and
serological data improved in infants within 4 months without treatment.
Conclusion: The evolution of cutaneous NLE may be the spontaneous regression of lesions within six months
without progression to Systemic Lupus Erytehmatosus.
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Background
Neonatal lupus erythematous (NLE) is an uncommon
autoimmune disease, first described by McCuiston and
Schoch in 1954 [1]. It is caused by the passage of mater-
nal antinuclear antibodies (ANA) and extractable nu-
clear antigen antibodies (ENA) through the placenta [2].
The most important ENA in the pathogenesis of disease
are anti-Ro/SSA, anti-La/SSB and less frequently anti-
U1 ribonucleoprotein RNP. At diagnosis, mothers are
asymptomatic in 40 to 60 % of cases. Antinuclear anti-
body tests could be used as a screening test in mothers
or patients suspected of having neonatal lupus erythe-
matosus [3].
The most common manifestations are cutaneous le-
sions, hematological or hepatic abnormalities and con-
genital heart block [4, 5]. The cutaneous findings are
variable and usually begin in the first weeks of life and
improve within 4 -6 months.
Four infants presenting with different cutaneous fea-
tures are described in this report, showing clinical and
laboratory differences which underline the variability of
this condition.
What is already known: Neonatal lupus erythematous
is a rare neonatal disease.
Novel Insights: Despite the positive family background
cutaneous and serological data resolution of skin lesions




The infant was born via spontaneous delivery, after pre-
mature rupture of membranes. Two days after birth he
was diagnosed with urinary tract infection and treated
with antibiotics for 10 days. Then he was discharged,
without any other problems. At 3 months of age, he
started to present skin lesions on the face and upper
limbs characterised by purpuric and erythematous fea-
tures. Suspecting a cutaneous mycosis, he was initially
but unsuccessfully treated with topic and systemic anti-
fungal agents for two weeks. Then, he was referred to
our Dermatologic Unit. At clinical examination, the in-
fant presented erythematous eruption with annular
patches and central regression, in particular over the
forehead and around the lips (Fig. 1). No further
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alterations were observed in the clinical evaluation. La-
boratory investigations at 3 months of age showed initial
mild anemia and thrombocytopenia that then improved.
IgA and IgM levels resulted quite low, reactive ANA
(1 > 320) with a fine-speckled nuclear pattern, reactive
anti-Ro/SSA (190 U/mL, normal value 0.00-10.00) and
anti-La/SSB (220 U/mL, normal value 0.00-10.00). Urine
tests, creatinine, C3 and C4 levels were normal. An elec-
trocardiogram (ECG) did not reveal heart block or any
other conduction defect. The mother’s laboratory inves-
tigation showed reactive ANA (1 > 640) with a fine-
speckled nuclear pattern, reactive anti-Ro/SSA (>240 U/
mL, normal value 0.00-10.00) and anti-La/SSB (> 320 U/
mL, normal value 0.00-10.00). She (33 year- old) was di-
agnosed as suffering from asymptomatic Sjögren Syn-
drome. Laboratory tests of the newborn were negative.
Family history, clinical and laboratory features were sug-
gestive of NLE, misdiagnosed as cutaneous mycosis. The
family was instructed to reduce sun exposure, use pro-
tective clothing and use sunscreen daily. Topic therapy
with hydrocortisone was started and performed for three
weeks, hematologic tests and laboratory tests were nor-
mal at 6 months of age.
Case 2
A full-term female was born to a 35-year-old from Perù
woman affected by systemic lupus erythematosus (SLE).
The serology tests of the newborn’s mother were positive
for both anti-Ro/SSA (186 U/mL) and anti-La/SSB (205
U/mL); her anti-ds-DNA antibodies were negative, anti-
CCP IgG and Rheumatoid factor were positive and C4
was reduced. The pregnancy was not complicated, all
the ultrasound scan controls were normal and the fetus
did not manifest any antenatal signs of congenital heart
block. Two days after birth, the newborn was referred to
our Department for the presence of upper and lower
eyelid angiomatous-like lesions featuring “eye-mask”
(Fig. 2). She presented unusual congenital erythematous
lesions with very fine scale and central clearing on her
face and a patch on her retroauricular region. No other
lesions were noted. The clinical setting and the family
history were suggestive for NLE, so laboratory evaluation
was performed. It was significant for a high-titer ANA
(>1/640) with a homogeneous immunofluorescent pat-
tern. ENA count was elevated (> 32 ratio, normal value
0.00-1.00), with both anti- Ro/SSA (268 U/mL) and anti-
La/SSB (320 U/mL); ENA Sm, ENA Sm/RNP, ENA
Scl70 and ENA anti Jo1 were negative. Hemoglobin and
platelet count were in the normal range. An ECG was
normal. The diagnosis of NLE was confirmed and care-
ful sun-protection of the skin was recommended. Be-
cause of the paucity of skin lesions, steroidal therapy
was not started. Three months later the skin lesions im-
proved and a reduction in ANA titer (1/320) was ob-
served. Total ENA count was still elevated, but we noted
a reduction in anti- Ro/SSA (193 U/mL). C3 and C4
were normal. At 7 months of age ANA titer was com-
pletely normalized and both anti-Ro/SSA and anti-La/
SSB further decreased. The ECG remained normal. We
followed up the patient annually for more than 4 years
and she remained asymptomatic for SLE, with complete
normalization of serology.
Case 3
A 3-months old female infant presented cutaneous le-
sions a few days after birth. She was born at term, after
an uncomplicated pregnancy and delivery. Personal and
family histories were negative. Clinical examination, re-
vealed widespread fine scale erythematous lesions, oc-
curring on the face, in particular on the lateral edges of
Fig. 1 case 1: Newborn with erythematous eruption with annular
patches and central regression, in particular over forehead and
around lips
Fig. 2 Case 2: Newborn with upper and lower eyelid angiomatous-like
lesions featuring “eye-mask”
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eyes and involving cheeks (Fig. 3). Slightly purplish atro-
phic areas were observed as spreading into the temple
regions bilaterally. The exams showed positive ENA (3.8
Ratio) and anti-Ro/SSA (226 U/mL), with negative
ANA, anti-La/SSB, anti-Sm, anti RNP, anti-Jo1, anti-
Scl70 and anti CENP. Renal function tests, albumin, cal-
cium, bilirubin, transaminases, erythrocyte sedimenta-
tion rate (ESR) and all other tests were normal. An ECG
was normal. A diagnosis of NLE was made and the in-
fant was treated with topic sunscreen. Follow up has not
shown any complications and serology for ENA and
antiRo/SSA was normal at 6 months of age. The 32 year
old mother’s lab data were positive for both anti-Ro/SSA
(191 U/mL), anti La/SSB (210 U/mL).
Case 4
The infant was referred to our Dermatologic Unit for
annular erythematosus lesions, located particularly on
the frontal-temporal surface, with a mildly atrophic cen-
tral area (Fig. 4). His mother (40 year-old) was affected
by Sjögren Syndrome with positive Ro/SSA (212 U/mL),
La/SSB (195 U/mL) and Rheumatoid factor. The new-
born presented positive serology for ENA, in particular
for Ro/SSA antibodies (> 47 U/mL), whereas La/SSB,
Sm, RNP, Scl70, JO1 and CENP were negative. The ECG
was normal. A clinical diagnosis of NLE was made,
based on cutaneous features and mother’s history. Sun
protection was proposed, without any pharmacological
therapy. All the cutaneous lesions disappeared in seven
months and serology was negative.
Conclusion
Neonatal Lupus Erythematosus is a rare neonatal im-
mune mediated disease. The true incidence is not yet
defined, because of underdiagnosis and misdiagnosis;
however, it is approximately 1:20000 live births and can
affect all ethnic groups [3]. Females are affected twice as
often as males [4]. In our Dermatologic Unit we visited
approximately 15600 children from 2003 to 2013 and
four of them were diagnosed with NLE. It is triggered by
transplacental passage of maternal IgG against Ro/SSA,
La/SSB and U1-RNP, after 16 weeks of gestational age.
Anti-La/SSB antibodies influence the development of
cutaneous NLE; instead anti-Ro/SSA antibodies are in-
volved in the development of NLE with complete heart
block. Other antibodies can be present, such as anti-
calreticulin, anti-fodrinand antibodies against a 57 kDa
protein and against a 75 kDa phosphoprotein [5]. There-
fore, fetal genetic components may contribute to the
pathogenesis of NLE or amplify the effect of the anti-
bodies [6]. As the IgG are maternally derived, cutaneous
forms of NLE are generally self-limiting in six-eight
months [7].
We found positive maternal serologies for Ro/SSA and
La/SSB in all the cases and one of them also presented a
positivity of anti-CCP and Rheumatoid factor, with a re-
duction in C4.
About 50 % of women with circulating auto-antibodies
who have children with NLE are asymptomatic, and
some of them will develop some kind of rheumatologic
disease, particularly Sjögren Syndrome, SLE and less
often mixed connective tissue diseases [3].
In our case series, one mother was affected by Sjögren
Syndrome, but she was asymptomatic and the diagnosis
was performed after NLE identification in her son; the
second one suffered from an already known SLE and the
Fig. 3 case 3: Newborn with widespread fine scale erythematous
lesions, occurring on the face, in particular on lateral edges of eyes
and involving cheeks
Fig. 4 case 4: Newborn with annular erythematosus lesions,
particularly located on the frontal-temporal surface, with a mildly
atrophic central area
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third one remained asymptomatic with anti-Ro/SSA; the
fourth mother was affected by Sjogren Syndrome.
Typical manifestations of NLE include transient
dermatitis, hepatic and hematologic abnormalities and
congenital heart block (Table 1) [8]. Non cutaneous
manifestations are described as quite frequent [2], but
only one of our cases had hematologic anormalities. No-
body of them presented hepatic failure and only in one
we reported a decrease in platelets count with spontan-
eous improvement. The most common extra-cutaneous
manifestation is cardiac involvement, which occurs in
2 % of newborns whose mothers are positive for Ro/SSA
or La/SSB [9]. The most serious complication is atrio-
ventricular block, which can be diagnosed in utero with
a routine ultrasound scan and is commonly referred to
as congenital complete block [10]. In our cases all preg-
nancies were uncomplicated and all the ultrasound con-
trols were normal without any antenatal signs of
congenital heart block.
Skin lesions are similar to subacute cutaneous SLE
and commonly consist of annular, erythematosus, scaly
plaques. Teleangectasia may be present, as in our second
case, and disordered angiogenesis can play a role in its
etiology [4]. Cutaneous lesions are typically localized on
the facial central areas and they can involve periocular,
perioral, zygomatic and temporal areas. Other lesions
can sometimes be found on the neck, scalps, arms.
Some criteria are reported in literature to define cuta-
neous NLE: characteristic lesions diagnosed within the
first year, with a photographic documentation, histologic
evidence of typical basal cell vasculopathy and mono-
nuclear cell infiltration, and anti-Ro/SSA or La/SSB or
U1-RNP antibodies in the mother or in the child. A me-
dian age of 6 weeks at diagnosis is described [4].
Only one of our cases presents early neonatal lesions,
although early presentation is often reported in literature
[2]. We did not perform the histological analysis, as it is
usually unnecessary [5].
Some differential diagnoses should be taken into ac-
count considering age, clinical features and localization.
Seborrheic dermatitis manifests rarely with round or an-
nular pattern of lesions and the scaly phase is more evi-
dent and yellowish [11]. Tinea capitis is not usually
diagnosed in newborns and the presence of another fam-
ily or contact case is essential to justify the infection.
Skin lesions have a centrifugal trend, with a more in-
flammatory nature [12]. Eyelid teleangectasias usually
present as salmon patches. They are capillary malforma-
tions with whole skin over, not scaly, and they do not
present a worsening evolution: within the first weeks of
life they become clearer, they do not increase in number
and they are rarely multiple and nummular [13]. Ery-
thema multiforme usually presents annular lesions, but
in the majority of cases is localized on extensor surface
of arms and not on face; moreover it usually appears as
a consequence of viral infection [14].
The typical evolution is the spontaneous regression of
the lesions within four or six months. However, skin le-
sions with a rich inflammatory component, particularly
on the fronto-temporal areas if misdiagnosed and not
protected against the sun, can result in semi-permanent
epidermic atrophy [4].
As concernes prognosis available data show that the ma-
jority of patients with NLE of the skin, liver, or blood have
transient disease that spontaneously resolves after 4-6
months. Also central nervous system abnormalities are
temporary such as Subependymal pseudocysts (SEPC) and
subependymal hemorrhage (SEH) observed using Cerebral
Ultrasound without any correlations to autoantibody levels
[15]; whether some sequelae occur is still unclear [16].
NLE can have substantial associated morbidity and mor-
tality if the heart is affected such as congenital heart block,
endocardial fibroelastosis and dilated cardiomyopathy
[17, 18].
The fourth of our patients presented fronto-temporal
lesions with a mildly atrophic central area, but they did
not result in permanent signs. In our patients, skin
lesions improved in a few months and we observed
progressive serological normalization.
No cases of SLE or renal lupus are reported in
children who presented NLE (as we observed in our
patients) [19–23].
When patients show skin lesions, exposure to direct
sunlight should be avoided. Topical steroids sometimes
reduce the evolution to atropy, whereas systemic
steroids are not indicated [3].
Table 1 NLE features
Cutaneous features Transient dermatitis with characteristic rash periorbital lesions or angiomatous-like lesions
Hematological features Hemolytic anemia, neutropenia, trombocytopenia
Liver features Hepatic abnormalities such as cholestasis and cytolsis
Cardiac features Congenital heart block, endocardial fibroelastosis and dilated cardiomyopathy
Neurological features Subependymal pseudocysts and Subependymal hemorrhage
Histology Basal cell vasculopathy and mononuclear cell infiltration
Laboratory tests Anti-Ro/SSA or Anti La/SSB or U1-RNP antibodies in the mother and in the child
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In conclusion, cutaneous NLE is a rare neonatal dis-
ease with a variable phenotype that may regress by the
age of 6 months. The diagnosis may be suggested by
characteristic cutaneous lesions and different pathologies
should be taken into account considering age, clinical
features and localization. Our experience shows that the
evolution of cutaneous NLE is the spontaneous regres-
sion of the lesions within six months without progres-
sion to SLE.
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